Optimization of Semha-Pinas Extract Orodispersible Tablets Using Response Surface Methodology
Abstract
The original dosage form of the Semha-Pinas herbal formula, an expectorant in Thai traditional medicine, is in a pill form. However, it is inconvenient to use because it must be powdered and dissolved in hot water or juice of Citrus x aurantium L. before use. The development of a new dosage form presents a challenging prospect. This work aimed to develop Semha-Pinas extract orodispersible tablets based on the response surface methodology using the Box-Behnken design. Firstly, Semha-Pinas extract was tested for its safety in HepG2 cells. The safe extract was further developed as orodispersible tablets. Four levels of three factors — compressional force (500–2,000 psi), the quantity of microcrystalline cellulose (0–15%), and the quantity of croscarmellose sodium and sodium starch glycolate (0:8–6:2%) — were screened using the one factor at a time technique. The Box-Behnken design has three levels for each factor: 1,000–2,000 psi, 5–15%, and 2:6–6:2%, respectively. Tablet thickness, hardness, friability, and disintegration time were the four responses that were monitored. The results indicated the safety of the Semha-Pinas extract, even at a concentration of 5 mg/mL. The optimal orodispersible tablet formulation had a compressional force of 1,500 psi, microcrystalline cellulose of 10%, and croscarmellose sodium to sodium starch glycolate of 4:4%. In summary, this study successfully fabricated Semha-Pinas extract orodispersible tablets using response surface methodology, achieving the desired property of fast disintegration. Moreover, these findings can serve as a valuable reference for pilot scale and industrial scale production.
Keywords
[1] R. H. Myers, D. C. Montgomery, and C. M. Anderson-Cook, “Response Surface methodology: process and product optimization using designed experiments,” New Jersey: John Wiley & Sons, 2016, p. 856.
[2] Develve, “Box-Behnken design,” 2022. [Online]. Available: https://develve.net/Box-Behnken%20 design.html
[3] Khun Sopit Banna Lak, “Kampee Phat Thai Phan Boran, Volume 3,” 1961. [Online]. Available: https://be7herb.wordpress.com/
[4] Center for Drug Evaluation and Research, “Guidance for Industry-Orally Disintegrating Tablets,” 2008. [Online]. Available: https://www. fda.gov/media/70877/download
[5] F. L. Lopez, T. B. Ernest, C. Tuleu, and M. O. Gul, “Formulation approaches to pediatric oral drug delivery: Benefits and limitations of current platforms,” Expert Opinion on Drug Delivery, vol. 12, pp. 1727–1740, 2015.
[6] P. Dey and S. Maiti, “Orodispersible tablets: A new trend in drug delivery,” Journal of Natural Science, Biology, and Medicine, vol. 1, pp. 2–5, 2010.
[7] B. P. Badgujar and A. S. Mundara, “The technologies used for developing orally disintegrating tablets: A review,” Acta Pharmaceutica, vol. 61, pp. 117–139, 2011.
[8] J. Suksaeree, C. Monton, L. Charoenchai, N. Chankana, and T. Wunnakup, “Optimization of process and formulation variables of Semha- Pinas extract effervescent tablets using Box- Behnken design,” AAPS PharmSciTech, vol. 42, p. 52, 2023.
[9] A. Chiangsom, R. Maniratanachote, D. Meksuriyen, R. Luechapudiporn, K. Kulthong, S. Aueviriyavit, S. Oda, T. Yokoi, and S. Lawanprasert, “Protective effect of Phikud Navakot extract against hydrogen peroxide-induced oxidative stress in HepG2 cells,” Thai Journal of Pharmaceutical Sciences, vol. 4, pp. 186–194, 2019.
[10] Biological Evaluation of Medical Devices, ISO 10993-5, International Organization for Standardization, Switzerland, 2009.
[11] R. Sharma and S. Sharma, “Physiology, blood volume,” 2020. [Online]. Available: https://www. ncbi.nlm.nih.gov/books/NBK526077/
[12] C. Monton, P. Kittiratpattana, S. Nakyai, T. Sutapakul, A. Navabhatra, T. Wunnakup, N. Chankana, and J. Suksaeree, “Microwave-assisted extraction of Clausena anisata leaves and Vernonia cinerea whole plants to maximize nitrate content: Optimization approach, antioxidant activity, and cytotoxicity,” Advances in Traditional Medicine, vol. 22, pp. 697–711, 2022.
[13] J. Suksaeree, A. Navabhatra, T. Wunnakup, and C. Monton, “Synergistic antioxidant activity and optimal microwave-assisted extraction condition of Caesalpinia sappan L., Hibiscus sabdariffa L., and Clitoria ternatea L. combinations,” Trends in Sciences, vol. 19, p. 3265, 2022.
[14] T. F. Herman and C. Santos, “First pass effect,” 2021. [Online]. Available: https://www.ncbi.nlm. nih.gov/books/NBK551679/
[15] A. Gopinath and M. Wilson, “Factors affecting drug absorption and distribution,” Anaesthesia and Intensive Care, vol. 21, pp. 223–228, 2020.
[16] L. Manley, J. Hilden, P. Valero, and T. Kramer, “Tablet compression force as a process analytical technology (PAT): 100% inspection and control of tablet weight uniformity,” Journal of Pharmaceutical Sciences, vol. 108, pp. 485–493, 2019.
[17] A. F. Marais, M. Song, and M. M. de Villiers, “Effect of compression force, humidity and disintegrant concentration on the disintegration and dissolution of directly compressed furosemide tablets using croscarmellose sodium as disintegrant,” Tropical Journal of Pharmaceutical Research, vol. 2, pp. 125–135, 2003.
[18] C. Monton, P. Keawchay, C. Pokkrong, P. Kamnoedthapaya, A. Navabhatra, J. Suksaeree, T. Wunnakup, N. Chankana, and T. Songsak, “Fabrication of direct compressible tablets containing Chatuphalathika extract obtained through microwave-assisted extraction: An optimization approach,” Scientia Pharmaceutica, vol. 91, p. 17, 2023.
[19] P. Pimhataivoot, P. Tipduangta, B. Sirithunyalug, and J. Sirithunyalug, “Versatile compression force measuring system for rotary tablet presses,” Chiang Mai University Journal of Natural Sciences, vol. 10, pp. 241–260, 2011.
[20] P. M. Desai, P. X. Er, C. V. Liew, and P. W. Heng, “Functionality of disintegrants and their mixtures in enabling fast disintegration of tablets by a quality by design approach,” AAPS PharmSciTech, vol. 15, pp. 1093–1104, 2014.
[21] J. Suksaeree, C. Monton, N. Chankana, and L. Charoenchai, “Application of microwave-assisted drying to shorten granules drying process for the preparation of Thunbergia laurifolia Lindl. leaf tablets,” Trends in Sciences, vol. 20, p. 4993, 2023.
[22] J. Suksaeree, C. Monton, L. Charoenchai, and N. Chankana, “Microwave-assisted drying of Prasakanphlu herbal granules and formulation development of Prasakanphlu tablets: Design of Experiments approach,” Advances in Traditional Medicine, In press, 2023, doi: 10.1007/s13596- 023-00681-7.
[23] R. C. Rowe, P. J. Sheskey, and M. E. Quinn, Handbook of Pharmaceutical Excipients. London: Pharmaceutical Press, 2009.
[24] A. Y. Chaerunisaa, S. Sriwidodo, and M. Abdassah, “Microcrystalline cellulose as pharmaceutical excipient,” in Pharmaceutical Formulation Design - Recent Practices, London: IntechOpen, pp. 1–21, 2019.
[25] G. Thoorens, F. Krier, B. Leclercq, B. Carlin, and B. Evrard, “Microcrystalline cellulose, a direct compression binder in a quality by design environment—A review,” International Journal of Pharmaceutics, vol. 473, pp. 64–72, 2014.
[26] M. Jivraj, L. G. Martini, and C. M. Thomson, “An overview of the different excipients useful for the direct compression of tablets,” Pharmaceutical Science & Technology Today, vol. 3, pp. 58–63, 2000.
[27] J. Suksaeree, C. Monton, N. Chankana, and L. Charoenchai, “Microcrystalline cellulose promotes superior direct compressed Boesenbergia rotunda (L.) Mansf. extract tablet properties to spray-dried rice starch and spray-dried lactose,” Arab Journal of Basic and Applied Sciences, vol. 30, pp. 13–25, 2023.
[28] P. Hiremath, K. Nuguru, and V. Agrahari. “Material Attributes and Their Impact on Wet Granulation Process Performance,” in Handbook of Pharmaceutical Wet Granulation, Massachusetts: Academic Press, pp. 263–315, 2019.
[29] J. Rojas, S. Guisao, and V. Ruge, “Functional assessment of four types of disintegrants and their effect on the spironolactone release properties,” AAPS PharmSciTech, vol. 13, pp. 1054–1062, 2012.
[30] Y. E. Apeji, F. D. Zechariah, S. N. Anyebe, B. Tytler, A. K. Olowosulu, and A. R. Oyi, “Effect of mode of superdisintegrant incorporation on tableting properties of metronidazole granules,” Pharmaceutical Sciences Asia, vol. 46, pp. 25–32, 2019.
[31] J. W. Tak, B. Gupta, R. K. Thapa, K. B. Woo, S.Y. Kim, T. G. Go, Y. Choi, J. Y. Choi, J. H. Jeong, H. G. Choi, C. S. Yong, and J. O. Kim, “Preparation and optimization of immediate release/sustained release bilayered tablets of loxoprofen using Box- Behnken design,” AAPS PharmSciTech, vol. 18, pp. 1125–1134, 2017.
[32] C. Narendra, M. S. Srinath, and G. Babu, “Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention,” AAPS PharmSciTech, vol. 7, pp. E23–E29, 2006.
[33] L. A. Soares, G. G. Ortega, P. R. Petrovick, and P. C. Schmidt, “Optimization of tablets containing a high dose of spray-dried plant extract: A technical note,” AAPS PharmSciTech, vol. 6, pp. E367–E371, 2005.
[34] M. L. Samala and R. B. Janga, “Design, statistical optimization of nizatidine floating tablets using natural polymer,” Future Journal of Pharmaceutical Sciences, vol. 7, p. 2, 2021.
[35] M. Gibson, Pharmaceutical Preformulation and Formulation: A Practical Guide from Candidate Drug Selection to Commercial Dosage Form. New York: Informa Healthcare, 2016.
[36] G. Steele, “Quality by Design (QbD) and the development and manufacture of drug substance,” in Pharmaceutical Quality by Design: A practical approach. New Jersey: John Wiley & Sons, pp. 61–95, 2018.
[37] D. Zakowiecki, P. Edinger, M. Papaioannou, T. Hess, B. Kubiak, and A. Terlecka, “Exploiting synergistic effects of brittle and plastic excipients in directly compressible formulations of sitagliptin phosphate and sitagliptin hydrochloride,” Pharmaceutical Development and Technology, vol. 27, pp. 702–713, 2022.
[38] H. F. Mostafa, M. A. Ibrahim, and A. Sakr, “Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: Effect of formulation and process variables,” Pharmaceutical Development and Technology, vol. 18, pp. 454–463, 2013.
[39] Y. Murase, K. Takayama, T. Uchimoto, H. Uchiyama, K. Kadota, and Y. Tozuka, “Prediction of tablet weight variability from bulk flow properties by sparse modeling,” Powder Technology, vol. 407, p. 117681, 2022.
[40] L. Gorgani, M. Mohammadi, G. D. Najafpour, and M. Nikzad, “Piperine—The bioactive compound of black pepper: From isolation to medicinal formulations,” Comprehensive Reviews in Food Science and Food Safety, vol. 16, pp. 124–140, 2017.
[41] K. V. Padalkar and V. G. Gaikar, “Extraction of piperine from Piper nigrum (black pepper) by aqueous solutions of surfactant and surfactant + hydrotrope mixtures,” Separation Science and Technology, vol. 43, pp. 3097–3118, 2008.
DOI: 10.14416/j.asep.2023.09.003
Refbacks
- There are currently no refbacks.
.png){kind=logo}
